<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829591</url>
  </required_header>
  <id_info>
    <org_study_id>ICIG2021</org_study_id>
    <nct_id>NCT04829591</nct_id>
  </id_info>
  <brief_title>A Multicenter Registry to Study the Characteristics and Outcomes of Jordanian Heart Failure Patients.</brief_title>
  <acronym>JoHFR</acronym>
  <official_title>The Jordanian Heart Failure Registry (JoHFR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Interventional Cardiovascular Innovation Group, Jordan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Interventional Cardiovascular Innovation Group, Jordan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart Failure research registry is a collection of computerized information about individuals&#xD;
      with heart failure. The database in this registry is obtained from several Jordanian medical&#xD;
      centers which will represent an extremely valuable resource for epidemiological research on&#xD;
      heart failure patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Understanding the cause of Heart Failure (HF) and how the body will respond to it, is&#xD;
      critical for an effective treatment. HF is a global problem with significant morbidity and&#xD;
      mortality, despite improved understanding of the pathophysiology and a growing range of&#xD;
      therapeutic options. Jordanian Heart Failure Registry (JoHFR) will be the first research&#xD;
      project of heart failure prevalence in Jordan. It is undertaken by primary healthcare&#xD;
      professionals with main aim to improve knowledge about the care of patients with HF. The&#xD;
      investigators responsible for conducting this research are physicians and their teams who&#xD;
      deal with heart failure patients in their outpatient and inpatient clinic centers including&#xD;
      the public and private medical sectors in Jordan's medical community. Standards in the&#xD;
      Hashemite kingdom of Jordan complies with the recognized good guideline directed medical&#xD;
      practices internationally&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>12 months</time_frame>
    <description>The main objective of the JoHFR is to obtain reliable estimate of rates of cardiovascular death and or hospitalization for decompensated heart failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>worsening kidney function</measure>
    <time_frame>12 months</time_frame>
    <description>as compared to baseline eGFR</description>
  </secondary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Heart Failure</condition>
  <condition>Chronic Heart Failure</condition>
  <condition>Acute Heart Failure</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observational</intervention_name>
    <description>Heart failure, non interventional</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients 18 years old and older with HF will be recruited from all over Jordan , resulting&#xD;
        in an initial sample estimate of approximately 4000 patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients who are 18 years or older with Heart Failure diagnosis as defined by&#xD;
             internationally recognized guidelines.&#xD;
&#xD;
          2. Current residents of the Hashemite Kingdom of Jordan&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who refuse or unable to sign a consent form.&#xD;
&#xD;
          2. Patient inability to follow up with provider&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hadi M Abu-Hantash, MD,MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Interventional Cardiovascular Innovation group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hadi M Abu-Hantash, MD, MSc</last_name>
    <phone>+962796721818</phone>
    <email>drhadi57@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mahmoud I Izraiq, MD</last_name>
    <phone>+962795652260</phone>
    <email>izraiq@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, Gomez-Mesa JE, Leong D, Ezekowitz J, Hage C, Lanas F, Maggioni AP, Sliwa K, Zhu J, Rouleau J, Balasubramanian K, Yusuf S; G-CHF Investigators. A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. Am Heart J. 2020 Sep;227:56-63. doi: 10.1016/j.ahj.2020.06.002. Epub 2020 Jun 6.</citation>
    <PMID>32679282</PMID>
  </reference>
  <reference>
    <citation>Savarese G, Vasko P, Jonsson Å, Edner M, Dahlström U, Lund LH. The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure. Ups J Med Sci. 2019 Jan;124(1):65-69. doi: 10.1080/03009734.2018.1490831. Epub 2018 Aug 9. Review.</citation>
    <PMID>30092697</PMID>
  </reference>
  <reference>
    <citation>Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, Ferrari R, Piepoli MF, Delgado Jimenez JF, Metra M, Fonseca C, Hradec J, Amir O, Logeart D, Dahlström U, Merkely B, Drozdz J, Goncalvesova E, Hassanein M, Chioncel O, Lainscak M, Seferovic PM, Tousoulis D, Kavoliuniene A, Fruhwald F, Fazlibegovic E, Temizhan A, Gatzov P, Erglis A, Laroche C, Mebazaa A; Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016 Jun;18(6):613-25. doi: 10.1002/ejhf.566. Erratum in: Eur J Heart Fail. 2017 Mar;19(3):438.</citation>
    <PMID>27324686</PMID>
  </reference>
  <reference>
    <citation>Bergethon KE, Ju C, DeVore AD, Hardy NC, Fonarow GC, Yancy CW, Heidenreich PA, Bhatt DL, Peterson ED, Hernandez AF. Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry. Circ Heart Fail. 2016 Jun;9(6). pii: e002594. doi: 10.1161/CIRCHEARTFAILURE.115.002594.</citation>
    <PMID>27301467</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Interventional Cardiovascular Innovation Group, Jordan</investigator_affiliation>
    <investigator_full_name>Hadi abu Hantash</investigator_full_name>
    <investigator_title>principle investigator and study chair</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 17, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT04829591/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 17, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT04829591/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

